Novartis To Build Cell-Culture Based Flu Vaccines Plant in US
Filed in archive Biotech Hubs and Facilities , Corporate and Industrial News , Diagnostics, Methodologies and Instrumentation , Drugs, Vaccines and Therapeutics on July 19, 2006
Novartis will build a $600 million plant in the United States to develop flu vaccines using advanced, cell-culture techniques. The facility would be based in holly Springs, North Carolina, and construction is expected to begin in 2007. Once operational, the plant is expected to manufacture up to 50 million doses of seasonal trivalent flu vaccines, which will be for use in the United States.
Part of this investment includes the $220 million grant Novartis received from the US Department of Health and Human Services in May, 2006.
More from AlertNet/Reuters.
Tags: vaccine flu biotech vaccines cell cell+culture novartis+build based+vaccines
Vote for Novartis To Build Cell-Culture Based Flu Vaccines Plant in US:
|
Rating: 8.00 out of 4 vote(s) cast.
|
| RSS |  |
 | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells